Frequency, Characteristics, Predictors and Treatment of Relapsing Myelin Oligodendrocyte Glycoprotein Antibody - Associated Disease (MOGAD)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) may have a monophasic or relapsing disease course. To date, factors that may predict a relapsing disease course remain largely unknown and only limited data exist regarding the efficacy of different utilized immunotherapy regimens at preventing or reducing relapses.